<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046019">
  <TermName>promegapoietin</TermName>
  <TermPronunciation>(proh-MEH-guh-POY-eh-tin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug given during chemotherapy to increase blood cell regeneration. Promegapoietin is a colony-stimulating factor that stimulates the production of blood cells, especially platelets. It is a cytokine and belongs to the family of drugs called hematopoietic (blood-forming) agents.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000707593" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;promegapoietin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000707594" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;promegapoyetina&quot;" language="es" id="_4"/>
  <SpanishTermName>promegapoyetina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento administrado durante la quimioterapia para aumentar la regeneración de las células sanguíneas. La promegapoyetina es un factor estimulante de colonias que estimula la producción de células sanguíneas, especialmente de las plaquetas. Es una citocina y pertenece al tipo de medicamentos llamados hematopoyéticos (formadores de la sangre).</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-03-19</DateLastModified>
</GlossaryTerm>
